|Last Price$195.60||Day Change (%)-1.17%|
|Open Price$199.11||Day Change ($)-2.32|
|Day Range194.65–200.00||52-Week Range145.12–242.37|
As of Thu 9/3/2015 2:25:00 PM | USD
Illumina , Warburg Pincus, and Sutter Hill Ventures Form Helix to Accelerate Consumer Adoption of Genomics
Illumina Accelerator Invests in Second Class of Genomics Startups from US and Europe
UPDATE: RainDance pulls IPO citing market conditions
RainDance pulls IPO, citing market conditions
Research and Markets: Global Automated Microbiology Market 2015-2019 - Examines Key Trends in the U.S, Five Major European Countries and Japan
Illumina ILMN reported second-quarter results Tuesday that beat our expectations, and we plan to raise our fair value estimate by several dollars per share. Revenue totaled $84.5 million for the quarter, a 103% increase from the year-ago period, which prompted the firm to significantly raise its ...
Continued technology advancements and market expansion support Illumina's narrow moat.
Research and Markets: US Molecular Diagnostic Product Suppliers 2015 - Sales and Market Shares by Test
Research and Markets: US Automated Microbiology Market 2015-2019 - Competitive Strategies, Supplier Shares, Country Segment Forecasts, Innovative Technologies & Instrumentation Review
Competitive advantages have improved for Mead Johnson, while De La Rue's moat was downgraded to narrow and POSCO was deemed a no-moat company.